Standout Papers

Interleukin-1–Receptor Antagonist in Type 2 D... 1987 2026 2000 2013 1.4k
  1. Interleukin-1–Receptor Antagonist in Type 2 Diabetes Mellitus (2007)
    Claus M. Larsen, Mirjam Faulenbach et al. New England Journal of Medicine
  2. Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. (1987)
    Richard N. Bergman, Rudolf Prager et al. Journal of Clinical Investigation

Immediate Impact

3 by Nobel laureates 15 from Science/Nature 135 standout
Sub-graph 1 of 13

Citing Papers

Inflammation in obesity, diabetes, and related disorders
2022 Standout
Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults
2018 Standout
108 intermediate papers

Works of Aage Vølund being referenced

Interleukin-1–Receptor Antagonist in Type 2 Diabetes Mellitus
2007 Standout
Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp.
1987 Standout
and 1 more

Author Peers

Author Last Decade Papers Cites
Aage Vølund 3315 2302 1106 2109 75 6.6k
Ngozi Erondu 5936 2583 341 3243 50 9.3k
Clive R. Pullinger 1437 2181 554 1703 121 5.8k
Mats Rudling 1896 2516 606 2230 97 7.8k
Tatsuya Kondo 1579 1172 535 3616 178 8.1k
Hiroshi Ikegami 2424 2724 2860 2050 212 6.8k
Jan Philippé 1432 1906 825 2122 206 5.9k
Kenneth H. Gabbay 3356 1686 1482 3920 114 10.9k
Robert J. Konrad 1197 2311 371 2145 149 6.8k
Kathrin Maedler 2249 3760 2228 2863 97 7.4k
Karin Bornfeldt 2116 1772 673 5096 151 10.8k

All Works

Loading papers...

Rankless by CCL
2026